Target intelligence / Profile preview

Keratin 14 (K14)

Target
K14
Molecular classification
Intermediate filament protein, Structural protein, Cytoskeletal protein, Type I keratin
01

Overview

Keratin 14 is a type I keratin and one of the main intermediate filament proteins expressed in the basal layer of the epidermis, where it forms obligatory heterodimers with keratin 5 to provide mechanical strength and resilience to keratinocytes[1][2][3][4]. Mutations in the keratin 14 gene (KRT14) impair filament assembly, leading to skin fragility syndromes such as epidermolysis bullosa simplex[1][2][3]. Keratin 14 is essential for cytoskeletal integrity, influences cell proliferation and differentiation, and plays a key role in maintaining the barrier function and homeostasis of stratified epithelia, such as skin[1][3][4]. K14 may also contribute to the regulation of signaling pathways involved in proliferation and differentiation, including the phosphatidylinositol 3-kinase/Akt and Notch pathways, and indirectly influences cellular responses to mechanical stress[4]. There are currently no known drugs that directly target keratin 14, but its genetic status serves as an important diagnostic marker for inherited blistering diseases[1][2].

Other names
Cytokeratin 14KRT14CK14
02

Mechanism of action

Not applicable (no established drugs directly target K14)

03

Biological functions

Structural support in keratinocytesEpidermal homeostasisSkin barrier maintenanceCell proliferation regulationRegulation of cell differentiationMechanotransduction (mechanical signaling)
04

Disease associations

Genetic skin disorders (notably epidermolysis bullosa simplex)Skin pigmentation disordersOther skin fragility conditions
05

Safety considerations

Null—loss or mutation causes skin fragility, blistering, barrier defects
06

Biomarkers

Mutation status (KRT14 genetic testing) as a diagnostic/prognostic marker for epidermolysis bullosa simplex

Beyond the preview

Go deeper on Keratin 14 (K14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 14 (K14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call